Glenmark Pharmaceuticals zooms on reporting 2-fold jump in Q1 consolidated net profit

17 Aug 2020 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 489.05, up by 13.65 points or 2.87% from its previous closing of Rs. 475.40 on the BSE.

The scrip opened at Rs. 495.10 and has touched a high and low of Rs. 508.50 and Rs. 482.50 respectively. So far 542903 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 572.70 on 22-Jun-2020 and a 52 week low of Rs. 168.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 508.50 and Rs. 453.50 respectively. The current market cap of the company is Rs. 13680.92 crore.

The promoters holding in the company stood at 46.62%, while Institutions and Non-Institutions held 28.93% and 24.44% respectively.

The company has reported a 2-fold jump net profit from continuing operations at Rs 462.48 crore for the first quarter ended June 30, 2020 as compared to Rs 227.84 crore for the same quarter in the previous year. Total income of the company increased by 15.98% at Rs 1,817.77 crore for Q1FY21 as compared Rs 1,567.33 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 2-fold jump in its net profit from continuing operations at Rs 254.04 crore for the quarter under review as compared to Rs 109.28 crore for the same quarter in the previous year. Total income of the company increased by 3.39% at Rs 2,403.30 crore for Q1FY21 as compared Rs 2,324.55 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1959.20 6.30 (0.32%)
11-Dec-2025 11:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.00
Dr. Reddys Lab 1269.00
Cipla 1501.55
Zydus Lifesciences 921.00
Lupin 2072.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×